Brief: CytoTools Reports Treatment Numbers In India Slightly Above Previous Quarter

bioXXmed AG

21/06/2021 08:32

June 21 (Reuters) - CYTOTOOLS AG  T5OG.DE :
    * TREATMENT NUMBERS IN INDIA SLIGHTLY ABOVE PREVIOUS QUARTER
DESPITE SIGNIFICANT PANDEMIC IMPACT
    * STILL EXPECTS TO BE ABLE TO REPORT INTERIM RESULTS OF
STUDY AT
END OF 2021 AND THEN TO SUCCESSFULLY COMPLETE PHASE III BY END
OF 2022
    * DESPITE DELAYS DUE TO PROGRESS OF COVID-19 IN EUROPE,
MANAGEMENT
BOARD ASSESSES CURRENT PROGRESS OF STUDY AS STILL ON TRACK
    * SALES OF WOXHEAL(R) IN INDIA HAVE INCREASED SLIGHTLY TO
OVER
10,000 USE CASES COMPARED TO Q4 OF 2020
    * CONFIDENT THAT NUMBER OF TREATMENTS CAN INCREASE
NOTICEABLY IN
SECOND HALF OF 2021 AND THAT ROLL-OUT OF PRODUCT WILL BE
ACCELERATED AS ORIGINALLY PLANNED

Source text for Eikon:  ID:nEQ34r1yGa 
Further company coverage:  T5OG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))